跳转至内容
Merck

N0290

Sigma-Aldrich

硝唑尼特

≥98% (HPLC)

别名:

NTZ; 2-乙酸基-N-(5-硝基-2-噻唑基)苯甲酰胺

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C12H9N3O5S
CAS号:
分子量:
307.28
EC 号:
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:
NACRES:
NA.77

质量水平

方案

≥98% (HPLC)

表单

powder

创始人

Romark

储存温度

2-8°C

SMILES字符串

CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+]([O-])=O

InChI

1S/C12H9N3O5S/c1-7(16)20-9-5-3-2-4-8(9)11(17)14-12-13-6-10(21-12)15(18)19/h2-6H,1H3,(H,13,14,17)

InChI key

YQNQNVDNTFHQSW-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般描述

硝唑尼特(NTZ)是一种噻唑化物类(thiazolide)化合物,它是一种结构与氯硝柳胺相似的抗寄生虫药。

应用

硝唑尼特已被用于:
  • 测试其对基孔肯雅病毒的抗病毒活性
  • 作为抗原生动物剂用于测试其对多种癌细胞系细胞活力的影响
  • 测试其对感染人巨细胞病毒(HCMV)的人成纤维细胞HFF细胞的影响

生化/生理作用

硝唑尼特是丙酮酸-铁氧还蛋白氧化还原酶(PFOR)抑制剂,FDA批准的抗寄生虫药(2002)。近期研究(C & EN Sept. 14, 2009, p. 28)表明,硝唑尼特可杀死非复制和复制的结核菌,未检测到明显的耐药性。
硝唑尼特是丙酮酸:铁氧还蛋白氧化还原酶(PFOR)的抑制剂;最近发现显示,这种抗菌剂可杀死非复制型和复制型分枝杆菌。
硝唑尼特(NTZ)通过作用于激酶信号传导通路来促进自噬,并作用于分枝杆菌中雷帕霉素复合物1(mTORC1)的哺乳动物靶点。体外研究中,它具有抗病毒特性,并有效地阻止了基孔肯雅病毒的进入和释放。NTZ还可以抑制早期阶段的日本脑炎病毒(JEV)感染,并具有治疗其他病毒感染的潜力,包括登革热、乙型肝炎(HBV)、冠状病毒和人类免疫缺陷病毒(HIV)。它具有抗恶性肿瘤功能,并可通过促进原癌基因c-Myc抑制来诱导细胞凋亡,从而导致肿瘤抑制。

特点和优势

该化合物由 Romark 开发。要浏览其他制药公司开发的化合物列表批准的药物/候选药物的列表, 点击这里

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Irit Krause et al.
The Pediatric infectious disease journal, 31(11), 1135-1138 (2012-07-20)
Cryptosporidium parvum is a common cause of diarrhea. In immunocompetent individuals, spontaneous recovery is the rule. In immunocompromised patients, it may cause a serious disease. Data on cryptosporidiosis in children after solid organ transplantation are few. We report on 6
Vanessa R Anderson et al.
Drugs, 67(13), 1947-1967 (2007-08-29)
Nitazoxanide (Alinia, Daxon, Dexidex, Paramix, Kidonax, Colufase, Annita) has in vitro activity against a variety of microorganisms, including a broad range of protozoa and helminths. Nitazoxanide is effective in the treatment of protozoal and helminthic infections, including Cryptosporidium parvum or
P Patrick Basu et al.
The American journal of gastroenterology, 106(11), 1970-1975 (2011-10-13)
Resistance to standard Helicobacter pylori (HP) treatment regimens has led to unsatisfactory cure rates in HP-infected patients. This study was designed to evaluate a novel four-drug regimen (three antibiotics and a proton pump inhibitor (PPI)) for eradication of HP infection
Nitazoxanide stimulates autophagy and inhibits mTORC1 signaling and intracellular proliferation of Mycobacterium tuberculosis
Lam KYK
PLoS Pathogens, 8(5), 340-351 (2012)
Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission
Wang YM, et al.
Antiviral Research, 135, 81-90 (2016)

商品

Bioactive small molecules for immune system signaling target identification/validation and antibiotics, antivirals, and antifungals offered.

Bioactive small molecules for immune system signaling target identification/validation and antibiotics, antivirals, and antifungals offered.

Bioactive small molecules for immune system signaling target identification/validation and antibiotics, antivirals, and antifungals offered.

Bioactive small molecules for immune system signaling target identification/validation and antibiotics, antivirals, and antifungals offered.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门